Phathom Pharmaceuticals (PHAT) Short Interest Ratio & Short Volume → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free PHAT Stock Alerts $10.62 -0.43 (-3.89%) (As of 03/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Phathom Pharmaceuticals Short Interest DataCurrent Short Volume10,440,000 sharesPrevious Short Volume8,670,000 sharesChange Vs. Previous Month+20.42%Dollar Volume Sold Short$88.64 millionShort Interest Ratio / Days to Cover13.0Last Record DateMarch 15, 2024Outstanding Shares58,480,000 sharesFloat Size26,030,000 sharesShort Percent of Float40.11%Today's Trading Volume886,406 sharesAverage Trading Volume818,636 sharesToday's Volume Vs. Average108% Short Selling Phathom Pharmaceuticals ? Sign up to receive the latest short interest report for Phathom Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPHAT Short Interest Over TimePHAT Days to Cover Over TimePHAT Percentage of Float Shorted Over Time Ad DTIWarning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…Watch the presentation here Phathom Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/202410,440,000 shares $88.64 million +20.4%40.1%13 $8.49 2/29/20248,670,000 shares $92.77 million -6.3%34.0%11.4 $10.70 2/15/20249,250,000 shares $63.83 million +7.2%36.3%13.2 $6.90 1/31/20248,630,000 shares $57.82 million +5.4%32.4%14.9 $6.70 1/15/20248,190,000 shares $61.92 million +15.7%30.8%14.3 $7.56 12/31/20237,080,000 shares $64.64 million +12.9%26.6%13.9 $9.13 Get the Latest News and Ratings for PHAT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Phathom Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/15/20236,270,000 shares $54.67 million +14.0%23.6%12.9 $8.72 11/30/20235,500,000 shares $38.45 million +12.9%20.9%10.5 $6.99 11/15/20234,870,000 shares $35.75 million +18.2%18.5%10.4 $7.34 10/31/20234,120,000 shares $38.32 million +4.3%16.1%9.6 $9.30 10/15/20233,950,000 shares $39.86 million +0.8%15.4%10.9 $10.09 9/30/20233,920,000 shares $40.65 million +42.0%15.3%11.2 $10.37 9/15/20232,760,000 shares $36.16 million -0.4%10.8%8 $13.10 8/31/20232,770,000 shares $39.86 million +7.0%11.0%9.3 $14.39 8/15/20232,590,000 shares $39.98 million -18.8%10.3%7.4 $15.44 7/31/20233,190,000 shares $48.52 million -25.8%12.2%9.4 $15.21 7/15/20234,300,000 shares $60.46 million +1.7%15.9%12.9 $14.06 6/30/20234,230,000 shares $60.57 million -3.0%14.8%11.4 $14.32 6/15/20234,360,000 shares $55.02 million +4.8%15.2%10.6 $12.62 5/31/20234,160,000 shares $48.92 million -8.0%20.2%10 $11.76 5/15/20234,520,000 shares $56.91 million -7.2%24.7%10.9 $12.59 4/30/20234,870,000 shares $52.11 million +0.4%33.1%11.7 $10.70 4/15/20234,850,000 shares $48.40 million +33.6%27.5%11.5 $9.98 3/31/20233,630,000 shares $25.92 million +18.6%20.8%8.4 $7.14 3/15/20233,060,000 shares $21.42 million +2.7%17.5%7.7 $7.00 2/28/20232,980,000 shares $25.51 million +10.8%15.8%8.4 $8.56 2/15/20232,690,000 shares $25.04 million +18.5%14.3%7.8 $9.31 1/31/20232,270,000 shares $27.08 million +8.6%12.1%8.9 $11.93 1/15/20232,090,000 shares $17.28 million +10.6%11.0%9.1 $8.27 12/30/20221,890,000 shares $21.21 million +18.9%10.0%9.2 $11.22 12/15/20221,590,000 shares $16.15 million -0.6%8.4%11.7 $10.16 11/30/20221,600,000 shares $15.97 million -5.3%8.4%7.7 $9.98 11/15/20221,690,000 shares $17.46 million -8.2%8.9%8 $10.33 10/31/20221,840,000 shares $19.50 million -8.5%11.1%8.1 $10.60 10/15/20222,010,000 shares $19.58 million -54.5%12.1%6.9 $9.74 9/30/20224,420,000 shares $48.97 million -22.5%26.7%15.6 $11.08 9/15/20225,700,000 shares $56.83 million -1.0%29.7%19.3 $9.97 8/31/20225,760,000 shares $49.19 million +4.9%30.1%23 $8.54 8/15/20225,490,000 shares $63.41 million +73.2%28.7%20.6 $11.55 7/31/20223,170,000 shares $29.20 million -1.9%16.6%9.7 $9.21Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… PHAT Short Interest - Frequently Asked Questions What is Phathom Pharmaceuticals' current short interest? Short interest is the volume of Phathom Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 15th, investors have sold 10,440,000 shares of PHAT short. 40.11% of Phathom Pharmaceuticals' shares are currently sold short. Learn More on Phathom Pharmaceuticals' current short interest. What is a good short interest ratio for Phathom Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PHAT shares currently have a short interest ratio of 13.0. Learn More on Phathom Pharmaceuticals's short interest ratio. Which institutional investors are shorting Phathom Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Phathom Pharmaceuticals: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Phathom Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 40.11% of Phathom Pharmaceuticals' floating shares are currently sold short. Is Phathom Pharmaceuticals' short interest increasing or decreasing? Phathom Pharmaceuticals saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 10,440,000 shares, an increase of 20.4% from the previous total of 8,670,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Phathom Pharmaceuticals' float size? Phathom Pharmaceuticals currently has issued a total of 58,480,000 shares. Some of Phathom Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Phathom Pharmaceuticals currently has a public float of 26,030,000 shares. How does Phathom Pharmaceuticals' short interest compare to its competitors? 40.11% of Phathom Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Phathom Pharmaceuticals: Olema Pharmaceuticals, Inc. (9.05%), Cogent Biosciences, Inc. (9.27%), SIGA Technologies, Inc. (13.70%), Nuvation Bio Inc. (1.97%), Calliditas Therapeutics AB (publ) (0.02%), Neurogene Inc. (3.42%), Mineralys Therapeutics, Inc. (5.75%), AnaptysBio, Inc. (17.86%), GH Research PLC (4.47%), COMPASS Pathways plc (5.09%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Phathom Pharmaceuticals stock? Short selling PHAT is an investing strategy that aims to generate trading profit from Phathom Pharmaceuticals as its price is falling. PHAT shares are trading down $0.43 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Phathom Pharmaceuticals? A short squeeze for Phathom Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PHAT, which in turn drives the price of the stock up even further. How often is Phathom Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PHAT, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: OLMA Short Squeeze COGT Short Squeeze SIGA Short Squeeze NUVB Short Squeeze CALT Short Squeeze NGNE Short Squeeze MLYS Short Squeeze ANAB Short Squeeze GHRS Short Squeeze CMPS Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PHAT) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyOnly a fool would buy Nvidia today… Porter & Company